top of page

It’s Time For The Marijuana Industry To Focus On Advocacy And Lobbying If It’s Going To Thrive (Op-Ed)

  • Writer: Bob Marley
    Bob Marley
  • Aug 11, 2023
  • 3 min read

“Why invest in a business that violates federal law and not act to change that law?”

By Aaron Smith, National Cannabis Industry Association

The cannabis industry is facing unprecedented challenges. People are losing money as an oversupply of product, labor shortages, supply chain disruptions and higher costs for key components like fertilizer, building materials and packaging are forcing companies to streamline operations as much as possible. Meanwhile, crushing regulatory environments and tax structures far more costly than any other industry continue to make finding financial success in cannabis very difficult.

In an effort to save money, cannabis businesses are moving away from the sort of advocacy that is necessary if the industry is going to remain sustainable, let alone improve. Unfortunately, this short-term thinking spells disaster.

The Time to Push for Reform Is Now

The current problems in the industry are moving people further away from what should be a prime directive: Federal policy reforms that will dramatically change cannabis in this country for the good.

What would the industry look like if businesses were no longer burdened by Section 280E of the Internal Revenue Code? This extreme taxation mandate effectively doubles or triples what cannabis business owners pay compared to small businesses in other industries. It creates an environment where some deep-pocketed companies can survive while all too many independent and craft operators are forced to close.

What would the industry look like with equal access to lending? How would legalized interstate commerce improve the bottom line for small cannabis companies? These are issues that the industry must address and work on to effect positive change.

Out of Sight, Out of Mind

Most of the industry’s current cash-flow problems are the result of federal prohibition. Congress did not act on the SAFE Banking Act last year and progress this year is frustratingly slow. Reforms to 280E and other much-needed policy proposals are under consideration but are still some years off.

To put it simply, until Congress is forced to make cannabis a priority, changes will not happen and institutional investors will continue to have cold feet due to the federal inaction. Which is why industry members must get involved to get their Congressional representatives and senators to understand why cannabis should be a priority and why they should act.

It’s a critical time for members of the cannabis industry to make their voices heard. Whether it is joining an advocacy group or contacting their congressperson directly (and repeatedly), the industry as a whole needs to speak up. If even half of those in the industry join forces, the chances for significant change increase dramatically.

With the disparities in lobbying at the federal level, it is the grassroots campaigns that will make a difference. As a whole, the cannabis industry spends very little on Capitol Hill, comparatively speaking, and the companies that are spending to lobby only represent a handful of cannabis operators.

For the few MSOs that are lobbying, they are primarily concerned with representing the interests of their company. Will the policies they are advocating benefit small businesses and Main Street Cannabis, or will it just mean more profits and market share for the few? It is essential to make sure that the playing ground is level for all cannabis operators—large and small—when federal legalization occurs.

There must be a unified voice for all cannabis businesses, especially small and independent operators, in the national dialogue around cannabis.

Choose Advocacy, Not Apathy

Business owners should budget for the worthwhile investment of advocacy work so they not only survive, but also have a chance to prosper. It is not necessarily Big Pharma, the alcohol industry or the tobacco lobby that might kill the legal cannabis industry. It is the industry’s own apathy that is more likely to be the cause of an implosion. The success of the industry is in our own hands and we need to get a seat at the table in order to make change.

Many cannabis operators and investors are hoping favorable reform will somehow happen by itself, which is akin to gambling their fortunes on the success of others. Why invest in a business that violates federal law and not act to change that law?

Aaron Smith is co-founder and chief executive officer of the National Cannabis Industry Association, the largest trade association representing legal cannabis businesses in the U.S. and the only one focused on representing independent cannabis businesses on a national level.

Biden Admin Has No Record Of Marijuana Letter Cited By DEA Head In Congressional Testimony

Recent Posts

See All

Comments


Global SEO Keywords

marihuana, cannabis, cáñamo, CBD, aceite de CBD, bálsamo de CBD, marijuana, hemp, weed, CBD oil, CBD balm, canapa, erba, olio di CBD, balsamo CBD, chanvre, herbe, huile de CBD, baume CBD, Marihuana, Cannabis, Hanf, Gras, CBD Öl, CBD Balsam, maconha, cânhamo, erva, óleo de CBD, bálsamo CBD, hennep, wiet, CBD olie, CBD balsem, hampa, gräs, CBD olja, CBD balsam, hamp, græs, gress, CBD olje, hamppu, ruoho, CBD öljy, CBD balsami, konopie, konopie indyjskie, olej CBD, balsam CBD, konopí, CBD olej, CBD balzám, konope, CBD balzam, marihuána, kannabisz, kender, fű, CBD olaj, CBD balzsam, canabis, cânepă, iarbă, ulei CBD, марихуана, канабис, коноп, CBD масло, CBD балсам, μαριχουάνα, κάνναβη, χασίς, λάδι CBD, βάλσαμο CBD, kanabis, konoplja, trava, CBD ulje, CBD olje, kanapės, kanapės indinės, CBD aliejus, CBD balzamas, marihuāna, kaņepes, CBD eļļa, CBD balzams, marihuaana, kanep, CBD õli, CBD palsam, kannabis, qanneb, żejt CBD, balsam CBD, marijúna, hampur, CBD olía, CBD smyrsl

Disclaimer

Jacob Hooy CBD Lip Balm is free from parabens and artificial colorants and contains no toxins or heavy metals, supporting natural body care. Our products are not intended to diagnose, treat, cure, or prevent any disease, medical condition, or symptom. The information provided on this website is for informational purposes only and must not be considered medical advice, nor a substitute for professional diagnosis, treatment, or guidance provided by qualified physicians, healthcare professionals, or pharmaceutical specialists. Nothing on this website should be interpreted as a recommendation, prescription, or therapeutic claim.

Difresh Spain is an online retail store registered under IAE Group 652.3, specializing in the retail trade of perfumery, cosmetic products, and personal hygiene and care items. NIF: Y3526859-F. E-mail: info@cbdvending.eu - WhatsApp: +34662918154 - Factory adress: Calle Albardín 13, Nave B07, 50720, La cartuja baja, Zaragoza, España. All prices include VAT and free shipping across all European Union countries.

© 2026 - www.cbdvending.euPrivacy Policy

bottom of page